**Executive Summary**
On May 20, 2026, U.S. Ambassador Sergio Gor and Union Minister Dr. Jitendra Singh met to expand bilateral cooperation in biotechnology, quantum technology, space, and nuclear energy. A landmark policy shift was highlighted, opening India's nuclear research sector to private investment for the first time, with final rules expected to be rolled out in the coming weeks. The meeting also proposed the establishment of a monthly working group to facilitate continuous engagement between Indian and U.S. investors and research institutions.
**Key Points / Main Content**
**Nuclear Sector Liberalization**
* India has opened nuclear research and nuclear medicine to the private sector to encourage investment in advanced cancer care and oncology research.
* The government remains the primary regulator for safeguards and security, but private participation is now permitted in areas previously confined to the public sector.
* Final rules governing this policy shift are anticipated to be released in the near future.
**Strategic Technology Frameworks**
* Collaborations are anchored in the U.S.-India TRUST initiative, focusing on AI, semiconductors, quantum technologies, and critical minerals.
* The National Quantum Mission has established four thematic hubs (computing, communication, sensing, and materials) and has achieved over 50% of its targets within three years.
* Institutional mechanisms for implementation include the IUSSTF, USISTEF, and the U.S. National Science Foundation.
**Healthcare and Biotechnology**
* India’s diverse genetic data pool is offered as a resource for global research in biotechnology, precision medicine, and AI-enabled diagnostics.
* New sequencing and AI tools aim to reduce healthcare delivery times, such as shortening 48-hour culture-based testing processes.
* The Biotechnology Industry Research Assistance Council (BIRAC) will serve as an interface for industry collaboration, with a similar mechanism proposed for nuclear medicine.
**Investment and Institutional Proposals**
* The Minister proposed a monthly working group with U.S. investors and companies to drive skilling, capital injection, and technical expertise.
* The Research, Development and Innovation Fund provides long-term unsecured financial support at 2–3% interest to encourage private sector R&D.
**Space and Advanced Research**
* Talks covered space cooperation including Starlink, quantum infrastructure, and technology transfer for thorium-based nuclear energy.
* Recent opening of the space sector to private participation has led to increased scope for collaboration with trusted international partners.
**Impact Analysis**
**Private Sector and Industry**
**Impact**
Gains access to previously restricted domains in nuclear research and space technology. Industry players can also access low-interest financial support for R&D through the Research, Development and Innovation Fund.
**Action Required**
Prepare investment strategies for nuclear medicine and oncology; monitor the rollout of final rules regarding nuclear sector participation.
**U.S. Investors and Research Institutions**
**Impact**
Offered a structured platform for collaboration through a proposed monthly working group to share technical expertise and capital.
**Action Required**
Participate in the proposed monthly working groups and engage with institutional mechanisms like BIRAC and USISTEF to facilitate knowledge exchange.
**Healthcare Providers and Researchers**
**Impact**
Benefitted by the availability of heterogeneous genetic data and emerging AI-enabled diagnostic tools that significantly reduce testing times.
**Action Required**
Adopt new sequencing technologies and AI diagnostics to improve healthcare delivery and participate in international oncology research collaborations.
Key Entities Referenced
U.S.-India TRUST initiative: A collaborative framework between the two nations focusing on artificial intelligence, semiconductors, quantum technologies, and space to build resilient supply chains.
National Quantum Mission: An Indian initiative aimed at developing quantum computing, communication, and sensing technologies through established thematic hubs.
Research, Development and Innovation Fund: A government initiative providing long-term unsecured financial support at low interest rates to encourage private sector participation in R&D.
Biotechnology Industry Research Assistance Council (BIRAC): A government interface used to facilitate industry-led collaboration and research in the biotechnology sector.
Indo-U.S. Science and Technology Forum (IUSSTF): An institutional mechanism identified to support the implementation of scientific cooperation and technology transfer between India and the U.S.
Ministry of Science & Technology
U.S. Ambassador Sergio Gor calls on Dr Jitendra
Singh, discusses expanding bilateral
collaborations across domains
India, U.S. explore trusted technology cooperation in biotech,
quantum and space
Nuclear research has been opened up to the private sector
for the first time in India, paving the way for new investment
opportunities, private sector participation, says the Minister
Dr. Jitendra Singh proposes regular working group with U.S.
investors
Posted On: 20 MAY 2026 5:29PM by PIB Delhi
U.S. Ambassador to India, Sergio Gor called on Union Minister Dr Jitendra Singh today and discussed
expanding bilateral collaborations in skilling, investment, knowledge exchange and industry-led
partnerships across domains in biotechnology, quantum technologies, space, atomic energy and nuclear
medicine.
The Minister said, nuclear research had been opened up to the private sector for the first time in India,
paving the way for new investment opportunities, private sector participation and international
collaboration in advanced cancer care, diagnostics, oncology research and genetic medicine.
Dr. Jitendra Singh said India’s major advantage lies in its large and heterogeneous genetic data pool, with
diverse population groups coexisting within the country. This, he noted, could be of significant value for
global research in biotechnology, precision medicine, AI-enabled diagnostics and future healthcare
solutions. He also underlined that emerging tool such as AI-enabled diagnosis, sequencing technologies
and faster testing methods could significantly reduce time in healthcare delivery, including processes that
otherwise take nearly 48 hours through conventional culture-based methods.
The Minister noted several measurable markers of cooperation and opportunity: four thematic hubs have
been established under the National Quantum Mission in quantum computing, communication, sensing
and metrology, and quantum materials and devices; India has achieved more than half of the Mission’s
targets in three years against an eight-year framework, he said.
The discussions were anchored in the U.S.-India TRUST initiative as a framework for cooperation among
governments, academia, industry and startups in artificial intelligence, semiconductors, quantum
technologies, biotechnology, energy, advanced materials, critical minerals and space technologies. Dr.
Jitendra Singh said the initiative’s emphasis on trusted technology partnerships, resilient supply chains,innovation ecosystems and protection of sensitive technologies was central to the next phase of India-U.S.
scientific cooperation. Existing platforms such as IUSSTF, USISTEF and cooperation with the U.S.
National Science Foundation were identified as institutional mechanisms to support implementation.
Highlighting a key policy shift, Dr. Jitendra Singh said India had opened up the nuclear sector and nuclear
medicine-related research and investment to private participation, while retaining safeguards and security
considerations. He said the move would enable private sector investment in areas that were earlier largely
confined to the public sector, and indicated that final rules could be rolled out in the coming weeks.
The two sides also discussed biotechnology, vaccine cooperation, regulatory harmonisation, oncology
trials, CAR-T therapy, AI-enabled diagnostics and the use of India’s diverse genetic data pool for global
research. BIRAC was cited as an interface for industry collaboration in biotechnology, with the possibility
of creating a similar facilitation mechanism for nuclear medicine.
On investment, Dr. Jitendra Singh referred to the Research, Development and Innovation Fund as a major
government initiative to bring the private sector into R&D investment. The fund, aimed primarily at
private sector participation, provides long-term unsecured financial support at about 2–3% interest,
enabling industry to become an equal partner in research and innovation.
Union Minister also proposed a regular working group, possibly meeting once a month, to take forward
investment, skilling, knowledge exchange and institutional collaboration with U.S. investors, companies
and research institutions. He said such engagement would help bring not only capital but also technical
expertise, private-sector experience and collaborative capacity into India’s emerging science and
technology sectors.
Space cooperation, Starlink, quantum infrastructure in the country, technology transfer for thorium-based
nuclear possibilities, and upcoming space engagements in Bengaluru also figured in the talks. Dr. Jitendra
Singh said India’s opening up of the space sector to private participation over the last five to six years had
led to a major leap, creating new scope for collaboration with trusted partners.****
NKR/AK
(Release ID: 2263321) Visitor Counter : 192
Read this release in: Urdu , Marathi , ही , Tamil